Brown University
Clinical trials sponsored by Brown University, explained in plain language.
-
App-Based peer support aims to boost opioid recovery during pandemic
Disease control OngoingThis study tests whether a smartphone app that connects people recovering from opioid use disorder with peer support can help them stay in treatment and improve their recovery. About 1,300 adults who own a smartphone and are in recovery or treatment for opioid use will use the ap…
Phase: NA • Sponsor: Brown University • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Immunotherapy duo aims to block Melanoma's return in High-Risk patients
Disease control OngoingThis study tests whether a combination of two immunotherapy drugs, nivolumab and low-dose ipilimumab, can prevent melanoma from returning in people who have had surgery to remove stage III or IV melanoma. The treatment is given every few weeks for six months. The main goals are t…
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New program aims to curb veteran suicides after hospital stays
Disease control OngoingThis study tests whether extra support after a hospital stay can help prevent suicide in high-risk veterans. 850 veterans will either get standard care or standard care plus a program called CLASP, which provides ongoing coping and support for 6 months. Researchers will track sui…
Phase: NA • Sponsor: Brown University • Aim: Disease control
Last updated May 16, 2026 23:46 UTC
-
Immunotherapy duo shows promise for rare, Tough-to-Treat ovarian cancer
Disease control OngoingThis study tests whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) works better than nivolumab alone for people with advanced clear cell ovarian, fallopian tube, or peritoneal cancer. About 46 participants will receive either one or both drugs to see if …
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 16, 2026 23:36 UTC
-
New drug cocktail aims to stop esophageal cancer from coming back
Disease control OngoingThis study looks at whether a 1-year treatment with two drugs (Enhertu and nivolumab) can safely prevent cancer from returning in people with HER2-positive esophageal or stomach-junction cancer. Participants have already completed standard therapy (chemoradiation and surgery) but…
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Brain tumor device combo study pulled before it started
Disease control TerminatedThis study was designed to test a device (NovoTTF-200A) combined with the immunotherapy drug pembrolizumab in people with melanoma that had spread to the brain. The goal was to see if the combination was safe and effective. However, the study was withdrawn before enrolling any pa…
Phase: PHASE1, PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
New program aims to cut HIV and violence among south african teen boys
Prevention OngoingThis study tests a program called Safe South Africa, designed to help teenage boys aged 15-17 reduce their risk of HIV and stop intimate partner violence. The program is being tested with 836 boys in South African high schools. Researchers will check if the program lowers new HIV…
Phase: PHASE3 • Sponsor: Brown University • Aim: Prevention
Last updated May 11, 2026 20:52 UTC
-
Healing through song: playlist therapy for broken hearts
Symptom relief OngoingThis study explores whether creating a personalized music playlist can help people cope with the loss of a spouse or life partner. Thirty adults from a grief support group will work with a researcher to build a playlist based on their feelings and memories. Surveys before and aft…
Phase: NA • Sponsor: Brown University • Aim: Symptom relief
Last updated May 16, 2026 23:51 UTC
-
New therapy aims to ease LGBTQ+ mental health crisis Post-COVID
Symptom relief OngoingThis study tests a brief, acceptance-based behavioral therapy to improve mental health in 240 LGBTQ+ adults who have mild anxiety or depression. Participants either receive the therapy or continue their usual care. The goal is to see if this short intervention can reduce symptoms…
Phase: PHASE2 • Sponsor: Brown University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Can AI help keep HIV patients in care? major study launches in kenya
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether machine learning can predict which HIV patients are likely to miss clinic visits or have treatment failure. Researchers will develop risk prediction tools and provide them to clinic staff in Kenya. They will compare outcomes between clinics using the tool…
Phase: NA • Sponsor: Brown University • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC